Jun 2026 $59 M No. 10 $50 to $250 million 19
K Health, Inc.: Raise no. 10, Jun 2026 × Investors in this round 19 investors had bought by the notice of Aug 19, 2026: 19 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $59 M of $69 M offered; $10 M still to sell
Smallest investment taken no minimum stated
What was sold equity Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Allon Bloch · Executive Officer, Director Chen Yehudai · Executive Officer Ran Shaul · Executive Officer Yaron Savoray · Executive Officer Zac Siegel · Executive Officer Adam Singolda · Director Alejandro Zubillaga · Director C. Okey Agba · Director Mark Tluszcz · Director Nir Zohar · Director Niyum Gandhi · Director Saad Ehtisham · Director Vivek Pattipati · Director Vivian Riefberg · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Allon Bloch, Chief Executive Officer. Source: SEC Form D, newest notice filed Aug 19, 2026. Read the notice at the SEC .
equity SEC Jul 2024 $88 M No. 9 $50 to $250 million 26
K Health, Inc.: Raise no. 9, Jul 2024 × Investors in this round 26 investors had bought by the notice of Jul 24, 2024: 26 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $88 M of $134 M offered; $46 M still to sell
Smallest investment taken no minimum stated
What was sold equity Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Allon Bloch · Executive Officer, Director Ashok Balakrishnan · Executive Officer Chen Yehudai · Executive Officer Ran Shaul · Executive Officer Yaron Savoray · Executive Officer Adam Singolda · Director Alejandro Zubillaga · Director Antonio Gracias · Director Hans Tung · Director Mark Tluszcz · Director Vivian Riefberg · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Yaron Savoray, Chief Financial Officer. Source: SEC Form D, newest notice filed Jul 24, 2024. Read the notice at the SEC .
equity SEC Jan 2021 $132 M No. 8 $50 to $250 million 16
K Health, Inc.: Raise no. 8, Jan 2021 × Investors in this round 16 investors had bought by the notice of Jan 19, 2021: 16 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $132 M of $132 M offered
Smallest investment taken no minimum stated
What was sold equity Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Allon Bloch · Executive Officer, Director Adam Singolda · Director Alejandro Zubillaga · Director Antonio Gracias · Director Hans Tung · Director Mark Tluszcz · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Allon Bloch, President. Source: SEC Form D, newest notice filed Jan 19, 2021. Read the notice at the SEC .
equity SEC Aug 2020 $37 M No. 7 $10 to $50 million 9
K Health, Inc.: Raise no. 7, Aug 2020 × Investors in this round 9 investors had bought by the notice of Nov 19, 2020: 9 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $37 M of $37 M offered
Smallest investment taken no minimum stated
What was sold equity Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Allon Bloch · Executive Officer, Director Adam Singolda · Director Alejandro Zubillaga · Director Mark Tluszcz · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Allon Bloch, President. Source: SEC Form D, newest notice filed Nov 19, 2020. Read the notice at the SEC .
equity SEC Feb 2020 $48 M No. 6 $10 to $50 million 21
K Health, Inc.: Raise no. 6, Feb 2020 × Investors in this round 21 investors had bought by the notice of Mar 5, 2020: 21 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $48 M of $50 M offered; $2 M still to sell
Smallest investment taken no minimum stated
What was sold equity Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Allon Bloch · Executive Officer, Director Adam Singolda · Director Alejandro Zubillaga · Director Mark Tluszcz · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Allon Bloch, President. Source: SEC Form D, newest notice filed Mar 5, 2020. Read the notice at the SEC .
equity SEC Jul 2019 $12 M No. 5 $10 to $50 million 1
K Health, Inc.: Raise no. 5, Jul 2019 × Investors in this round 1 investor had bought by the notice of Jul 23, 2019: 1 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $12 M (amount offered: indefinite)
Smallest investment taken no minimum stated
What was sold equity Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last more than a year
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Allon Bloch · Executive Officer, Director Adam Singolda · Director Alejandro Zubillaga · Director Mark Tluszcz · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Allon Bloch, President. Source: SEC Form D, newest notice filed Jul 23, 2019. Read the notice at the SEC .
equity SEC Dec 2018 $25 M No. 4 $10 to $50 million 15
K Health, Inc.: Raise no. 4, Dec 2018 × Investors in this round 15 investors had bought by the notice of Dec 19, 2018: 15 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $25 M of $25 M offered
Smallest investment taken no minimum stated
What was sold equity Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Allon Bloch · Executive Officer, Director Adam Singolda · Director Alejandro Zubillaga · Director Mark Tluszcz · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Allon Bloch, President. Source: SEC Form D, newest notice filed Dec 19, 2018. Read the notice at the SEC .
equity SEC Jan 2018 $5 M No. 3 $2 to $10 million 10
K Health, Inc.: Raise no. 3, Jan 2018 × Investors in this round 10 investors had bought by the notice of Jan 30, 2018: 10 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $5 M of $6 M offered; $0 M still to sell
Smallest investment taken no minimum stated
What was sold equity Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Allon Bloch · Executive Officer, Director Adam Singolda · Director Mark Tluszcz · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Allon Bloch, President. Source: SEC Form D, newest notice filed Jan 30, 2018. Read the notice at the SEC .
equity SEC Jun 2017 $3 M No. 2 $2 to $10 million 7
K Health, Inc.: Raise no. 2, Jun 2017 × Investors in this round 7 investors had bought by the notice of Jun 13, 2017: 7 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $3 M of $3 M offered
Smallest investment taken no minimum stated
What was sold equity Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Allon Bloch · Executive Officer, Director Adam Singolda · Director Mark Tluszcz · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Allon Bloch, President. Source: SEC Form D, newest notice filed Jun 13, 2017. Read the notice at the SEC .
equity SEC Nov 2016 $3 M No. 1 $2 to $10 million 11
K Health, Inc.: Raise no. 1, Nov 2016 × Investors in this round 11 investors had bought by the notice of Nov 21, 2016: 11 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $3 M of $3 M offered; $0 M still to sell
Smallest investment taken no minimum stated
What was sold equity Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Allon Bloch · Executive Officer, Director Adam Singolda · Director Mark Tluszcz · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Allon Bloch, President. Source: SEC Form D, newest notice filed Nov 21, 2016. Read the notice at the SEC .
equity SEC